You're offline — showing cached data
B BibaMoneypowered by AI OS

Merck & Co., Inc.

MRK · NYSE
Healthcare · Drug Manufacturers - General
Market cap
P/E (TTM)
Net margin
Revenue / share

About Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company operating through two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment develops and markets human health products, including prescription drugs for oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes, as well as preventive vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals and vaccines for livestock and companion animals.

Why it matters

Merck is one of the largest pharmaceutical companies globally, with a diversified portfolio spanning key therapeutic areas and vaccines. Its blockbuster drugs like Keytruda (pembrolizumab) in oncology and Gardasil in vaccines drive significant revenue. Investors monitor Merck for its scale, R&D pipeline, and position in the competitive healthcare sector, where it faces peers like Pfizer and Johnson & Johnson.

Company site ↗

How we research MRK

Fundamentals like the ones above feed our fundamental screen — EPS acceleration, ROE and momentum∧quality — the one research class that survives walk-forward in our testing. We don’t issue price targets or buy/sell calls: see /edge for how rigorously (and how rarely) anything passes. This page is market data and research, not investment advice.

Data updated 00:00 UTC, 26 Jun 2026 · source: Financial Modeling Prep via AI OS.